Zuellig declared its business scope to acting sales activity for drug manufacturers.

Published: 2000-05-02 16:15:00

Updated: 2000-05-02 16:15:00

Zuellig Pharma Korea, a multinational drug wholesale company, started their sales activity from April 10, and President Tony Hausbierld explained in the official press interview on April 27 that Zuellig's business should be understood as a drug distribution company of not engaging in any conventi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK